Fancm-deficient mice reveal unique features of Fanconi anemia complementation group M

Human Molecular Genetics

Volumn 18, Issue 18, 2009, Pages 3484-3495

  Bakker, Sietske T ^a,b   van de Vrugt, Henri J ^b   Rooimans, Martin A ^b   Oostra, Anneke B ^b   Steltenpool, Jurgen ^b   Delzenne Goette, Elly ^a   van der Wal, Anja ^a   van der Valk, Martin ^a   Joenje, Hans ^b   te Riele, Hein ^a   de Winter, Johan P ^b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FANCONI ANEMIA GROUP M PROTEIN; FANCONI ANEMIA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CELL VIABILITY; CHROMATID; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EXON; FANCONI ANEMIA; FIBROBLAST; GENE DELETION; GENE DISRUPTION; GENE MUTATION; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENOMIC INSTABILITY; HYPOGONADISM; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION;

ALLELES; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OVARY; PHENOTYPE; SISTER CHROMATID EXCHANGE; SURVIVAL RATE; TESTIS;

MUS;

EID: 69449102249     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp297     Document Type: Article

References (54)

1. Wang,W. (2007) Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat. Rev. Genet., 8, 735-748.
2. de Winter, J.P. and Joenje, H. (2008) The genetic and molecular basis of Fanconi anemia. Mutat. Res. [Epub ahead of print November 14], PMID: 19061902.
3. Auerbach, A.D. and Wolman, S.R. (1976) Susceptibility of Fanconi's anaemia fibroblasts to chromosome damage by carcinogens. Nature, 261, 494-496.
4. Joenje, H. and Patel, K.J. (2001) The emerging genetic and molecular basis of Fanconi anaemia. Nat. Rev. Genet., 2, 446-457.
5. Grompe, M. and van de Vrugt, H. (2007) The Fanconi family adds a fraternal twin. Dev. Cell, 12, 661-662.
6. Meetei, A., de Winter, J., Medhurst, A., Wallisch, M., Waisfisz, Q., van de Vrugt, H., Oostra, A., Yan, Z., Ling, C., Bishop, C. et al. (2003) A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet., 35, 165-170.
7. Smogorzewska, A., Matsuoka, S., Vinciguerra, P., McDonald, E.R. III, Hurov, K.E., Luo, J., Ballif, B.A., Gygi, S.P., Hofmann, K., D'Andrea, A.D. and Elledge, S.J. (2007) Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell, 129, 289-301.
8. Ciccia, A., Ling, C., Coulthard, R., Yan, Z., Xue, Y., Meetei, A.R., Laghmani el, H., Joenje, H., McDonald, N., de Winter, J.P. et al. (2007) Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM. Mol. Cell, 25, 331-343.
9. Meetei, A.R., Sechi, S., Wallisch, M., Yang, D., Young, M.K., Joenje, H., Hoatlin, M.E. and Wang, W. (2003) A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome. Mol. Cell Biol., 23 3417-3426.
10. Ling, C., Ishiai, M., Ali, A.M., Medhurst, A.L., Neveling, K., Kalb, R., Yan, Z., Xue, Y., Oostra, A.B., Auerbach, A.D. et al. (2007) FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway. EMBO J., 26, 2104-2114.
11. Machida, Y.J., Machida, Y., Chen, Y., Gurtan, A.M., Kupfer, G.M., D'Andrea, A.D. and Dutta, A. (2006) UBE2T is the E2 in the Fanconi anemia pathway and undergoes negative autoregulation. Mol Cell, 23, 589-596.
12. Taniguchi, T., Garcia-Higuera, I., Andreassen, P.R., Gregory, R.C., Grompe, M. and D'Andrea, A.D. (2002) S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood, 100, 2414-2420.
13. Howlett, N.G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G. et al. (2002) Biallelic inactivation of BRCA2 in Fanconi anemia. Science 297, 606-609.
14. Levitus, M., Waisfisz, Q., Godthelp, B.C., de Vries, Y., Hussain, S., Wiegant, W.W., Elghalbzouri-Maghrani, E., Steltenpool, J., Rooimans, M.A., Pals, G. et al. (2005) The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat. Genet., 37, 934-935.
15. Xia, B., Dorsman, J.C., Ameziane, N., de Vries, Y., Rooimans, M.A., Sheng, Q., Pals, G., Errami, A., Gluckman, E., Llera, J. et al. (2007) Fanconi anemia is associated with a defect in the BRCA2 partner PALB2. Nat. Genet., 39, 159-161.
16. Blom, E., van de Vrugt, H.J., de Winter, J.P., Arwert, F. and Joenje, H. (2002) Evolutionary clues to the molecular function of fanconi anemia genes. Acta Haematol., 108, 231-236.
17. Meetei, A.R., Medhurst, A.L., Ling, C., Xue, Y., Singh, T.R., Bier, P., Steltenpool, J., Stone, S., Dokal, I., Mathew, C.G. et al. (2005) A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat. Genet., 37, 958-963.
18. Mosedale, G., Niedzwiedz, W., Alpi, A., Perrina, F., Pereira-Leal, J.B., Johnson, M., Langevin, F., Pace, P. and Patel, K.J. (2005) The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway. Nat. Struct. Mol. Biol., 12, 763-771.
19. Wu, L. and Hickson, I.D. (2006) DNA helicases required for homologous recombination and repair of damaged replication forks. Annu. Rev. Genet., 40, 279-306.
20. Gari, K., Decaillet, C., Stasiak, A.Z., Stasiak, A. and Constantinou, A. (2008) The Fanconi anemia protein FANCM can promote branch migration of Holliday junctions and replication forks. Mol. Cell, 29, 141-148.
21. Gari, K., Decaillet, C., Delannoy, M., Wu, L. and Constantinou, A. (2008) Remodeling of DNA replication structures by the branch point translocase FANCM. Proc. Natl. Acad. Sci. USA, 105, 16107-16112.
22. Singh, T.R., Bakker, S.T., Agarwal, S., Jansen, M., Grassman, E., Godthelp, B.C., Ali, A.M., Du, C.H., Rooimans, M.A., Fan, Q. et al. (2009) Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M. Blood. [Epub ahead of print May 7], PMID: 19423727.
23. Chen, M., Tomkins, D.J., Auerbach, W., McKerlie, C., Youssoufian, H., Liu, L., Gan, O., Carreau, M., Auerbach, A., Groves, T. et al. (1996) Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia. Nat. Genet., 12, 448-451.
24. Whitney, M.A., Royle, G., Low, M.J., Kelly, M.A., Axthelm, M.K., Reifsteck, C., Olson, S., Braun, R.E., Heinrich, M.C., Rathbun, R.K. et al. (1996) Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene. Blood, 88, 49-58.
25. Cheng, N.C., van de Vrugt, H.J., van der Valk, M.A., Oostra, A.B., Krimpenfort, P., de Vries, Y., Joenje, H., Berns, A. and Arwert, F. (2000) Mice with a targeted disruption of the Fanconi anemia homolog Fanca. Hum. Mol. Genet., 9, 1805-1811.
26. Wong, J.C., Alon, N., McKerlie, C., Huang, J.R., Meyn, M.S. and Buchwald, M. (2003) Targeted disruption of exons 1 to 6 of the Fanconi Anemia group A gene leads to growth retardation, strain-specific microphthalmia, meiotic defects and primordial germ cell hypoplasia. Hum. Mol. Genet., 12, 2063-2076.
27. Koomen, M., Cheng, N.C., van de Vrugt, H.J., Godthelp, B.C., van der Valk, M.A., Oostra, A.B., Zdzienicka, M.Z., Joenje, H. and Arwert, F. (2002) Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice. Hum. Mol. Genet., 11, 273-281.
28. Yang, Y., Kuang, Y., Montes de Oca, R., Hays, T., Moreau, L., Lu, N., Seed, B. and D'Andrea, A.D. (2001) Targeted disruption of the murine Fanconi anemia gene, Fancg/Xrcc9. Blood, 98, 3435-3440.
29. Agoulnik, A.I., Lu, B., Zhu, Q., Truong, C., Ty, M.T., Arango, N., Chada, K.K. and Bishop, C.E. (2002) A novel gene, Pog, is necessary for primordial germ cell proliferation in the mouse and underlies the germ cell deficient mutation, gcd. Hum. Mol. Genet., 11, 3047-3053.
30. Houghtaling, S., Timmers, C., Noll, M., Finegold, M.J., Jones, S.N., Meyn, M.S. and Grompe, M. (2003) Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes. Dev., 17, 2021-2035.
31. Carreau, M., Gan, O.I., Liu, L., Doedens, M., McKerlie, C., Dick, J.E. and Buchwald, M. (1998) Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage. Blood, 91, 2737-2744.
32. Wong, J.C. and Buchwald, M. (2002) Disease model: Fanconi anemia. Trends Mol. Med., 8, 139-142.
33. Carreau, M. (2004) Not-so-novel phenotypes in the Fanconi anemia group D2 mouse model. Blood, 103, 2430.
34. Akkari, Y., Bateman, R., Reifsteck, C., D'Andrea, A., Olson, S. and Grompe, M. (2001) The 4 N cell cycle delay in fanconi anemia reflects growth arrest in late S phase. Mol. Genet. Metab., 74, 403-412.
35. Kubbies, M., Schindler, D., Hoehn, H., Schinzel, A. and Rabinovitch, P.S. (1985) Endogenous blockage and delay of the chromosome cycle despite normal recruitment and growth phase explain poor proliferation and frequent edomitosis in Fanconi anemia cells. Am. J. Hum. Genet. 37, 1022-1030.
36. Xue, Y., Li, Y., Guo, R., Ling, C. and Wang, W. (2008) FANCM of the Fanconi anemia core complex is required for both monoubiquitination and DNA repair. Hum. Mol. Genet., 17, 1641-1652.
37. Kim, J.M., Kee, Y., Gurtan, A. and D'Andrea, A.D. (2008) Cell cycle-dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24. Blood, 111, 5215-5222.
38. Rosado, I.V., Niedzwiedz, W., Alpi, A.F. and Patel, K.J. (2009) The Walker B motif in avian FANCM is required to limit sister chromatid exchanges but is dispensable for DNA crosslink repair. Nucleic Acids Res. [Epub ahead of print May 21], PMID: 19465393.
39. Noll, M., Battaile, K.P., Bateman, R., Lax, T.P., Rathbun, K., Reifsteck, C., Bagby, G., Finegold, M., Olson, S. and Grompe, M. (2002) Fanconi anemia group A and C double-mutant mice: Functional evidence for a multi-protein Fanconi anemia complex. Exp. Hematol., 30, 679-688.
40. Cranston, A., Bocker, T., Reitmair, A., Palazzo, J., Wilson, T., Mak, T. and Fishel, R. (1997) Female embryonic lethality in mice nullizygous for both Msh2 and p53. Nat. Genet., 17, 114-118.
41. Cranston, A. and Fishel, R. (1999) Female embryonic lethality in Msh2-Trp53 nullizygous mice is strain dependent. Mamm. Genome, 10, 1020-1022.
42. Freie, B., Li, X., Ciccone, S.L., Nawa, K., Cooper, S., Vogelweid, C., Schantz, L., Haneline, L.S., Orazi, A., Broxmeyer, H.E. et al. (2003) Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis. Blood, 102, 4146-4152.
43. Houghtaling, S., Granville, L., Akkari, Y., Torimaru, Y., Olson, S., Finegold, M. and Grompe, M. (2005) Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice. Cancer Res., 65, 85-91.
44. Hickson, I.D. (2003) RecQ helicases: Caretakers of the genome. Nat. Rev. Cancer, 3, 169-178.
45. Banerjee, S., Smith, S., Oum, J.H., Liaw, H.J., Hwang, J.Y., Sikdar, N., Motegi, A., Lee, S.E. and Myung, K. (2008) Mph1p promotes gross chromosomal rearrangement through partial inhibition of homologous recombination. J. Cell Biol., 181, 1083-1093.
46. Prakash, R., Satory, D., Dray, E., Papusha, A., Scheller, J., Kramer, W., Krejci, L., Klein, H., Haber, J.E., Sung, P. and Ira, G. (2009) Yeast Mph1 helicase dissociates Rad51-made D-loops: Implications for crossover control in mitotic recombination. Genes Dev., 23, 67-79.
47. Sun, W., Nandi, S., Osman, F., Ahn, J.S., Jakovleska, J., Lorenz, A. and Whitby, M.C. (2008) The FANCM ortholog Fml1 promotes recombination at stalled replication forks and limits crossing over during DNA double-strand break repair. Mol. Cell, 32, 118-128.
48. Joenje, H., Arwert, F., Eriksson, A.W., de Koning, H. and Oostra, A.B. (1981) Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia. Nature, 290, 142-143.
49. Medhurst, A.L., Laghmani el, H., Steltenpool, J., Ferrer, M., Fontaine, C., de Groot, J., Rooimans, M.A., Scheper, R.J., Meetei, A.R., Wang, W. et al. (2006) Evidence for subcomplexes in the Fanconi anemia pathway. Blood, 108, 2072-2080.
50. Kennedy, R.D., Chen, C.C., Stuckert, P., Archila, E.M., De la Vega, M.A., Moreau, L.A., Shimamura, A. and D'Andrea, A.D. (2007) Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated. J. Clin. Invest., 117, 1440-1449.
51. van de Vrugt, H.J., Cheng, N.C., de Vries, Y., Rooimans, M.A., de Groot, J., Scheper, R.J., Zhi, Y., Hoatlin, M.E., Joenje, H. and Arwert, F. (2000) Cloning and characterization of murine fanconi anemia group A gene: Fanca protein is expressed in lymphoid tissues, testis, and ovary. Mamm. Genome, 11, 326-331.
52. Graumann, J., Hubner, N., Kim, J., Ko, K., Moser, M., Kumar, C., Cox, J., Scholer, H. and Mann, M. (2008) Stable isotope labeling by amino acids in cell culture (SILAC) and proteome quantitation of mouse embryonic stem cells to a depth of 5,111 proteins. Mol. Cell. Proteomics, 7, 672-683.
53. Mojas, N., Lopes, M. and Jiricny, J. (2007) Mismatch repair-dependent processing of methylation damage gives rise to persistent single-stranded gaps in newly replicated DNA. Genes Dev., 21 3342-3355.
54. Perry, P. and Wolff, S. (1974) New Giemsa method for the differential staining of sister chromatids. Nature, 251, 156-158.